# Neural Responses and Dysphoria: Modulation by a Pharmacological Probe

> **NCT01101685** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 160 (estimated)

## Conditions studied

- Dysphoria

## Interventions

- **DRUG:** Escitalopram
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01101685
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2011-03
- **Final completion:** 2011-03
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2011-06-07

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01101685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01101685, "Neural Responses and Dysphoria: Modulation by a Pharmacological Probe". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01101685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*